Saira Ramasastry, a director at $MIRM, sold 2,000 shares of the company on 05-15-2026 for an estimated $218,940. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $MIRM stock.
$MIRM Insider Trading Activity
$MIRM insiders have traded $MIRM stock on the open market 30 times in the past 6 months. Of those trades, 1 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $MIRM stock by insiders over the last 6 months:
- MICHAEL G GREY has made 0 purchases and 3 sales selling 150,000 shares for an estimated $11,100,000.
- PATRICK J HERON purchased 131,425 shares for an estimated $8,999,984
- CHRISTOPHER PEETZ (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 4 sales selling 64,022 shares for an estimated $6,030,112.
- PETER RADOVICH (PRESIDENT AND COO) has made 0 purchases and 4 sales selling 24,671 shares for an estimated $2,315,438.
- SAIRA RAMASASTRY has made 0 purchases and 8 sales selling 17,000 shares for an estimated $1,519,880.
- JOANNE QUAN (CHIEF MEDICAL OFFICER) has made 0 purchases and 3 sales selling 16,020 shares for an estimated $1,464,134.
- ERIC BJERKHOLT (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 9,761 shares for an estimated $904,148.
- JOLANDA HOWE (SVP, GLOBAL CONTROLLER) has made 0 purchases and 4 sales selling 7,468 shares for an estimated $702,650.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MIRM Hedge Fund Activity
We have seen 181 institutional investors add shares of $MIRM stock to their portfolio, and 153 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,318,909 shares (+204.0%) to their portfolio in Q1 2026, for an estimated $121,840,813
- JANUS HENDERSON GROUP PLC added 1,067,722 shares (+21.4%) to their portfolio in Q4 2025, for an estimated $84,339,360
- TCG CROSSOVER MANAGEMENT, LLC added 1,000,000 shares (+1611.6%) to their portfolio in Q1 2026, for an estimated $92,380,000
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. added 884,563 shares (+13.0%) to their portfolio in Q1 2026, for an estimated $81,715,929
- CAPITAL WORLD INVESTORS added 724,415 shares (+inf%) to their portfolio in Q1 2026, for an estimated $66,921,457
- EVENTIDE ASSET MANAGEMENT, LLC removed 684,711 shares (-32.7%) from their portfolio in Q1 2026, for an estimated $63,253,602
- PARADIGM BIOCAPITAL ADVISORS LP added 625,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $57,737,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MIRM Analyst Ratings
Wall Street analysts have issued reports on $MIRM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 05/07/2026
To track analyst ratings and price targets for $MIRM, check out Quiver Quantitative's $MIRM forecast page.
$MIRM Price Targets
Multiple analysts have issued price targets for $MIRM recently. We have seen 11 analysts offer price targets for $MIRM in the last 6 months, with a median target of $132.0.
Here are some recent targets:
- Brian Skorney from Baird set a target price of $129.0 on 05/07/2026
- Lisa Walter from RBC Capital set a target price of $142.0 on 05/07/2026
- Joseph Thome from TD Cowen set a target price of $145.0 on 05/07/2026
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $138.0 on 05/07/2026
- Michael Ulz from Morgan Stanley set a target price of $140.0 on 05/05/2026
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $175.0 on 05/04/2026
- James Condulis from Stifel set a target price of $130.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
